Record NNP B-NP O
date NN I-NP O
: : O O
2079-11-15 CD O B-DATE
November NNP B-NP B-DATE
15 CD I-NP I-DATE
, , I-NP I-DATE
2079 CD O I-DATE
Xan NNP B-NP B-DOCTOR
Dillon NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
75 CD B-NP B-STREET
East NNP I-NP I-STREET
Dunstable NNP I-NP I-STREET
Road NNP I-NP I-STREET
Nouakchott NNP B-NP B-CITY
, , O O
GA NNP B-NP B-STATE
95269 CD I-NP B-ZIP
RE RB B-ADVP O
: : O O
Urania NNP B-NP B-PATIENT
Yerger NNP I-NP I-PATIENT
MR NNP B-NP O
# # I-NP O
583-48-90-0 CD O B-MEDICALRECORD
Dear NNP B-NP O
Dr. NNP I-NP O
Dillon NNP I-NP B-DOCTOR
: : O O
I PRP B-NP O
had VBD B-VP O
the DT B-NP O
pleasure NN I-NP O
of IN B-PP O
seeing VBG B-VP O
Urania NNP B-NP B-PATIENT
Yerger NNP I-NP I-PATIENT
today NN I-NP O
in IN B-PP O
Titonka NNP B-NP B-HOSPITAL
Care NNP I-NP I-HOSPITAL
Center NNP I-NP I-HOSPITAL
in IN B-PP O
follow-up NN B-NP O
of IN B-PP O
her PRP$ B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
( -LRB- I-NP O
CABG JJ I-NP O
10/78 CD I-NP B-DATE
) -RRB- I-NP O
and CC I-NP O
heart NN I-NP O
failure NN I-NP O
. . O O
At IN B-ADVP O
her PRP$ B-NP O
last JJ I-NP O
visit NN I-NP O
her PRP$ O O
heart NN B-NP O
failure NN I-NP O
had VBD B-VP O
improved VBN I-VP O
, , O O
but CC O O
she PRP B-NP O
still RB B-ADVP O
was VBD B-VP O
hypertensive JJ B-ADJP O
. . O O
We PRP B-NP O
increased VBD B-VP O
both DT O O
her PRP$ B-NP O
Losartan NNP I-NP O
and CC O O
her PRP$ B-NP O
Toprol NNP I-NP O
dosing NN I-NP O
. . O O
Today NN B-VP O
her PRP$ B-NP O
blood NN I-NP O
pressure NN I-NP O
is VBZ B-VP O
substantially RB I-VP O
improved VBN I-VP O
. . O O
She PRP B-NP O
has VBZ B-VP O
generally RB I-VP O
been VBN I-VP O
feeling VBG B-VP O
well RB B-ADVP O
. . O O
She PRP B-NP O
has VBZ B-VP O
continued VBN I-VP O
to TO I-VP O
walk VB I-VP O
outside IN B-PP O
the DT B-NP O
home NN I-NP O
with IN B-PP O
her PRP$ B-NP O
daughters NNS I-NP O
, , O O
going VBG B-VP O
shopping NN B-NP O
. . O O
She PRP B-NP O
denies VBZ B-VP O
orthopnea NN B-NP O
or CC O O
PND. NNP B-NP O
She PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
stable JJ B-NP O
ankle NN I-NP O
edema NN I-NP O
. . O O
Her PRP$ B-NP O
current JJ I-NP O
medications NNS I-NP O
are VBP B-VP O
aspirin RB B-NP O
325 CD I-NP O
mg NN I-NP O
PO NN I-NP O
q NN I-NP O
. . B-NP O
day NN I-NP O
, , O O
Lasix NNP B-NP O
40 CD I-NP O
mg NN I-NP O
PO NNP I-NP O
q NNP I-NP O
. . B-NP O
day NN I-NP O
, , O O
Glipizide NNP B-NP O
10 CD I-NP O
mg NN I-NP O
PO NNP B-NP O
q NN I-NP O
. . B-NP O
day NN I-NP O
, , O O
Losartan NNP B-NP O
100 CD I-NP O
mg NN I-NP O
PO NN I-NP O
q NN I-NP O
. . B-NP O
day NN I-NP O
, , O O
Toprol NNP B-NP O
XL NNP I-NP O
100 CD I-NP O
mg NN I-NP O
PO NN I-NP O
q NN I-NP O
. . B-NP O
day NN I-NP O
, , O O
Simvastatin NNP B-NP O
10 CD I-NP O
mg NN I-NP O
PO NNP I-NP O
q NNP I-NP O
. . O O
day NN B-NP O
, , O O
Avandia NNP B-NP O
, , O O
and CC O O
multivitamins NNS B-NP O
. . O O
On IN B-PP O
physical JJ B-NP O
examination NN I-NP O
, , O O
her PRP$ B-NP O
blood NN I-NP O
pressure NN I-NP O
today NN I-NP O
is VBZ B-VP O
130/60 CD B-NP O
. . O O
Her PRP$ B-NP O
heart NN I-NP O
rate NN I-NP O
is VBZ B-VP O
in IN B-PP O
the DT B-NP O
high JJ I-NP O
60s NNS I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
comfortable JJ B-ADJP O
seated VBN B-VP O
on IN B-PP O
the DT B-NP O
examination NN I-NP O
table NN I-NP O
. . B-VP O
Her PRP$ B-NP O
jugular JJ I-NP O
venous JJ I-NP O
pressure NN I-NP O
is VBZ B-VP O
less JJR B-NP O
than IN I-NP O
8. CD I-NP O
Her PRP$ B-NP O
chest NN I-NP O
examination NN I-NP O
has VBZ B-VP O
a DT B-NP O
few JJ I-NP O
coarse JJ I-NP O
crackles NNS I-NP O
at IN B-PP O
the DT B-NP O
bases NNS I-NP O
. . O O
Cardiac NNP B-NP O
examination NN I-NP O
reveals VBZ B-VP O
a DT O O
non-displaced JJ B-NP O
PMI NNP I-NP O
with IN B-PP O
normal JJ B-NP O
intensity NN I-NP O
S1 NNP I-NP O
and CC I-NP O
S2 NNP I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
a DT B-NP O
grade NN I-NP O
II/V IN B-PP O
I PRP B-NP O
holosystolic VB B-VP O
murmur VBG I-VP O
at IN B-PP O
the DT B-NP O
apex NN I-NP O
and CC O O
a DT B-NP O
grade NN I-NP O
II NNP I-NP O
crescendo/decrescendo NN I-NP O
systolic JJ I-NP O
murmur NN I-NP O
at IN B-PP O
the DT B-NP O
right JJ I-NP O
upper JJ I-NP O
sternal NN I-NP O
border NN B-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
1 LS B-NP O
- : O O
2+ JJ B-NP O
edema NN I-NP O
of IN B-PP O
both DT B-NP O
lower JJR I-NP O
extremities NNS I-NP O
and CC O O
they PRP B-NP O
are VBP B-VP O
warm JJ B-ADJP O
to TO B-VP O
touch VB I-VP O
. . O O
Her PRP$ B-NP O
ECG NNP I-NP O
reveals VBZ B-VP O
sinus IN B-PP O
rhythm NN B-NP O
at IN B-PP O
68 CD B-NP O
beats NNS I-NP O
per IN B-PP O
minute NN B-NP O
, , O O
normal JJ B-NP O
axis NN I-NP O
and CC I-NP O
intervals NNS I-NP O
. . O O
There EX B-NP O
are VBP O O
nonspecific JJ B-NP O
ST NNP I-NP O
abnormalities NNS I-NP O
. . O O
Overall RB B-ADVP O
, , O O
Ms. NNP B-NP O
Yerger NNP I-NP B-PATIENT
has VBZ B-VP O
improved VBN I-VP O
significantly RB B-ADVP O
with IN B-PP O
better JJR B-NP O
control NN I-NP O
of IN B-PP O
her PRP$ B-NP O
blood NN I-NP O
pressure NN I-NP O
. . O O
She PRP O O
has VBZ O O
signs NNS B-NP O
of IN B-PP O
very RB B-NP O
mild JJ I-NP O
volume NN I-NP O
overload NN I-NP O
on IN B-PP O
examination NN B-NP O
, , O O
with IN B-PP O
preserved JJ B-NP O
perfusion NN I-NP O
. . O O
We PRP B-NP O
elected VBN O O
to TO B-VP O
maintain VB I-VP O
her PRP$ B-NP O
present JJ I-NP O
dosing NN I-NP O
, , O O
but CC O O
discussed VBD B-VP O
increasing VBG I-VP O
her PRP$ B-NP O
dose NN I-NP O
to TO B-PP O
40 CD B-NP O
mg NN I-NP O
PO NNP I-NP O
q NNP I-NP O
. . O O
a.m. RB O O
and CC O O
20 CD B-NP O
mg NN I-NP O
PO NNP B-NP O
q RB B-ADVP O
. . O O
p.m. RB B-ADVP O
should MD B-VP O
her PRP B-NP O
lower JJR B-NP O
extremity NN I-NP O
edema NN I-NP O
increase NN I-NP O
or CC O O
her PRP$ B-NP O
weight NN I-NP O
rise NN I-NP O
. . O O
Urania NNP B-NP B-PATIENT
Yerger NN I-NP I-PATIENT
MR NNP B-NP O
# # I-NP O
583-48-90-0 CD O B-MEDICALRECORD
Page NNP B-NP O
2 CD I-NP O
November NNP B-NP B-DATE
15 CD I-NP I-DATE
, , I-NP I-DATE
2079 CD O I-DATE
I PRP B-NP O
look VBP B-VP O
forward RB B-ADVP O
to TO B-PP O
seeing VBG B-VP O
her PRP B-NP O
again RB B-ADVP O
in IN B-PP O
approximately RB B-NP O
six CD I-NP O
months NNS I-NP O
. . O O
It PRP B-NP O
was VBD B-VP O
a DT B-NP O
pleasure NN I-NP O
being VBG B-VP O
involved VBN I-VP O
in IN B-PP O
her PRP$ B-NP O
care NN I-NP O
. . O O
Please VB B-VP O
do VBP I-VP O
not RB O O
hesitate VB B-VP O
to TO I-VP O
contact VB I-VP O
me PRP B-NP O
with IN B-PP O
any DT B-NP O
questions NNS I-NP O
. . O O
Sincerely RB B-ADVP O
yours PRP B-NP O
, , O O
Vaughn NNP B-NP B-DOCTOR
A. NN I-NP I-DOCTOR
Xander NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
/ NN B-NP O
uhl NN I-NP B-DOCTOR
